<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in many countries, including Malaysia </plain></SENT>
<SENT sid="1" pm="."><plain>The accumulation of genomic alterations is an important feature of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A better understanding of the molecular events underlying the stages of colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> might be helpful in the detection and management of the disease </plain></SENT>
<SENT sid="3" pm="."><plain>We used a commercially available single-nucleotide polymorphism genotyping array to detect both copy number abnormalities (CNAs) and copy-neutral loss of heterozygosity (LOH) in <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Matched <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissues of 13 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (Dukes' stages A-D) were analyzed using a 250K single nucleotide polymorphism array </plain></SENT>
<SENT sid="5" pm="."><plain>An additional assay was performed to determine the microsatellite instability status by using the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute-recommended BAT-26 panel </plain></SENT>
<SENT sid="6" pm="."><plain>In general, copy number gain (92.3%) was most common, followed by copy number loss (53.8%) and copy-neutral LOH (46.2%) </plain></SENT>
<SENT sid="7" pm="."><plain>Frequent CNAs of gains and losses were observed on chromosomes 7p, 8, 13q, 17p, 18q, and 20q, and copy-neutral LOH was observed on chromosomes 2, 6, 12, 13q, 14q, 17, 20p, 19q, and 22q </plain></SENT>
<SENT sid="8" pm="."><plain>Even though genomic alterations are associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression, our results showed that DNA CNAs and copy-neutral LOH do not reflect disease progression in at least 50% <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Copy-neutral LOH was observed in both early and advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, which favors the involvement of these genomic alterations in the early stages of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
</text></document>